Nutrigenomics Testing Market Size By Application (Obesity, Diabetes, Cancer, Cardiovascular Diseases), By Distribution Channel (Hospitals & Clinics, Online Platform), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, UAE), Application Potential, Competitive Market Share & Forecast, 2019 - 2025
Nutrigenomics Testing Market will exceed USD 800 million by 2025; as per a new research report.
Rising number of obese people will surge demand for nutrigenomics testing kits over the analysis timeframe. Nutrigenomics testing enables nutritionists to recommend personalized diet for obese people to control their weight and maintain healthy lifestyle. Obesity is one of the prominent factors for chronic disease progression such as diabetes and cardiovascular disorders that results in hazardous life-threatening repercussions. Obese people are increasingly preferring nutrigenomics testing in order to enhance eating habits. Aforementioned factors will escalate nutrigenomics testing market growth in forthcoming future.
Rapid advances in genomics and molecular biology will be a high impact rendering factor for nutrigenomics testing market growth over the forecast period. Nutrigenomics testing enables in detection of food effects on an individual’s body that further helps in preventing onset of diseases such as cancer, diabetes and obesity. Technologically advanced nutrigenomic panels help nutritionists to suggest exercise and personalized diet-based disease management. Advantages of nutrigenomics testing in maintaining healthy lifestyle will rise its preference over the forecast period. However, stringent regulations may restraint the industry growth to certain extent.
Diabetes segment of nutrigenomics testing market was valued more than USD 70 million in 2018 and it is anticipated to witness significant growth over the forecast period. Nutritional genomics testing broadens understanding of patterns pertaining to genetic variations, epigenetic modifications, and gene diet phenotype interactions. It also enables comprehensive understanding of early molecular events occurred in diabetes that may prevent further complexities and disease progression. As a result, nutrigenetics testing has pivotal role in diabetes management and care that will fuel its demand over the analysis timeframe.
Hospitals and clinics segment is anticipated to witness around 10.5% CAGR over the forecast period. Significant growth can be attributed to increasing number of patients opting treatment for chronic diseases from hospitals and clinics. For chronic disease management, doctors often recommend nutrigenetic tests that will fuel its demand. Industry players commercialize superior quality nutrigenomics testing kits to healthcare facilities that may positively boost segment growth in forthcoming future.
Japan nutrigenomics testing market was accounted for more than 35% revenue share of Asia Pacific industry in 2018 and it is anticipated to witness significant growth over the forecast period. Considerable revenue can be attributed to several factors such as increasing preference towards personalized diet and rising prevalence of chronic diseases. Moreover, industry players in the region are undertaking various activities in order to provide efficient nutrigenomics tests. Also, various startups have been established to offer superior quality nutrigenomics testing kits, thereby accelerating country growth over the forecast period.
Notable industry players operational in the nutrigenomics testing market include Sanger Genomics, Gene Box, Metagenics, CURA INTEGRATIVE MEDICINE, Orig3n, Pathway Genomics, Holistic Heal, Nutrigenomix, Xcode Life, Salugen, GX Sciences and NutraGene. These industry players are implementing several strategic initiatives such as collaborations, mergers, acquisitions, product launches and emphasis on R&D activities in order to gain competitive advantage and sustain market competition. For instance, in November 2017, Orig3n acquired Interleukin Genetics, a genome based personalized health organization. This acquisition aimed at providing Inherent Health genetic tests for heart health, weight management and bone health. This activity will help company to capture higher market share that will enable it to exceed its business revenue.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook